Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 9, 1998, Pages 893-897

  Cooper, B T ^a   Neumann, C S ^a   Cox, M A ^a   Iqbal, T H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; EPITHELIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES;

EID: 0031688734     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00389.x     Document Type: Article

References (31)

1. Cooper BT, Barbezat GO. Barrett's oesophagus: a clinical study of 52 cases. Q J Med 1987; 62: 97-108.
2. Tytgat GNJ, Hameetman W, Onstenk RR, Scotborg R. The spectrum of columnar lined-Barrett's oesophagus. Endoscopy 1989; 21: 177-85.
3. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar lined (Barrett's) esophagus. Gastroenterology 1990; 99: 918-22.
4. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing evidence of adenocarcinoma of the esophagus and esophago-gastric junction. Gastroenterology 1993; 104: 510-13.
5. Brand DL, Ylvisaker JF, Gelfand M, Pope CE. Regression of the columnar esophageal (Barrett's) epithelium after anti-reflux surgery. N Engl J Med 1980; 302: 844-8.
6. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's esophagus. Ann Surg 1983; 198: 554-65.
7. Starnes BA, Adkins RB, Ballinger JF. Barrett's esophagus: a surgical entity. Arch Surg 1984; 119: 563-7.
8. Williamson WA, Ellis FH, Gibb SP, Shahian DM, Aretz HT. Effects of anti-reflux operation on Barrett's mucosa. Ann Thor Surg 1990; 49: 537-42.
9. Cooper BT, Barbezat GO. Treatment of Barrett's oesophagus with H2 blockers. J Clin Gastroenterol 1987; 9: 139-41.
10. Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on the extent of Barrett's esophagus in 67 patients. Dig Dis Ssi 1990; 35: 93-6.
11. Havelund T, Laursen LS, Anderson BN, et al. Omeprazole and ranitidine treatment of reflux oesophagitis. Br Med J 1988; 296: 89-92.
12. Bardhan KD, Morris P, Thompson M, et al. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine. Gut 1990; 31: 745-9.
13. Lundell L, Backmann L, Elstrom P, et al. Omeprazole or high dose ranitidine in the treatment of patients with reflux oesophagitis not responding to standard doses of H2 receptor antagonists. Aliment Pharmacol Ther 1990; 4: 144-55.
14. Deviere J, Buset M, Dumonceau JM, Rickaert F, Cremer M, Regression of Barrett's epithelium with omeprazole. N Engl J Med 1989; 320: 1498.
15. Salis GB, Milano C, Chiocca JC, et al. Treatment of Barrett's epithelium with omeprazole. Gullet 1993; 3: 46-9.
16. Gore S, Healey CJ, Sutton R, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993; 7: 623-28.
17. Peters ETM, Ganesh E, Kuipers E, et al. Regression of Barrett's esophagus during omeprazole; a double blinded study. Gastroenterology 1997; 112: A638(Abstract).
18. Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long term therapy with high dose omeprazole. Gastrointest Endosc 1996; 44: 700-5.
19. Patterson JE, Perkins S, Gillon K, Stoddard CJ. The effect of omeprazole on columnar mucosal regression in Barrett's esophagus: Results at 2 years. Gastroenterology 1995; 108: A188(Abstract).
20. Shaffer RT, Francis J, Carrougher JC, Kadakia SC. Effect of omeprazole on Barrett's esophagus after 3 years therapy. Gastroenterology 1996; 110: A255(Abstract).
21. Weinstein WF, Lieberman DA, Landis KJ, Weber LJ, Berger ML, Ippoliti AF. Omeprazole induced regression of Barrett's esophagus: a 2 year randomised controlled double blind trial. Gastroenterology 1996; 110: A294(Abstract).
22. Sampliner RE. Effect of up to 3 years of high dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994; 89: 1844-8.
23. Sharma P, Sampliner RE, Camargo E. Normalisation of esophageal pH with high dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997; 92: 582-5.
24. Neumann CS, Iqbal TH, Cooper BT. Long term continuous treatment of patients with Barrett's oesophagus. Aliment Pharmacol Ther 1995; 9: 451-4.
25. Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M, Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-8.
26. Howden CW, Horning CA. Do proton pump inhibitors induce regression of Barrett's esophagus? - a systematic review. Gastroenterology 1997; 112: A152(Abstract).
27. Ippoliti AF, Weinstein WF, Lieberman DA, Berger ML. Resistance to high dose antisecretory drugs in Barrett's esophagus. Gastroenterology 1997; 112: A583(Abstract).
28. Champion G, Richter JE. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994; 107: 747-54.
29. Sampliner RE, Steinbronn K, Garewal HS, Riddell RH. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery. Am J Gastroenterol 1988; 83: 510-12.
30. Berensen MM, Johnson TD, Markowitz NR, Buchi KN, Samowiitz WS. Restoration of squamous mucosa after ablation of Barrett's epithelium. Gastroenterology 1993; 104: 1686-91.
31. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett's esophagus. Sem Surg Oncol 1995; 11: 372-6.